Work

Development and validation of circulating tumor cell (Epic Sciences) enumeration as a prognostic biomarker in men with metastatic castration-resistant prostate cancer.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.6_suppl.157

Authors: Howard I. Scher, Andrew J. Armstrong, Joseph D. Schonhoft, Audrey Gill, Jimmy Zhao, Ethan Barnett, Emily Carbone, James Lu, Emmanuel S. Antonarakis, Jun Luo, Scott T. Tagawa, Qian Yang, Daniel J. George, Russell Zelig Szmulewitz, Daniel Costin Danila, Rick Wenstrup, Mithat Gonen, Susan Halabi

Institutions: Memorial Sloan Kettering Cancer Center, Duke University, Duke Cancer Institute, Johns Hopkins University, Johns Hopkins Medicine, Epic Sciences (United States), Sidney Kimmel Comprehensive Cancer Center, Weill Cornell Medicine, University of Chicago, Duke Medical Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3134745828

Cites:

Cited by:

Related to: 10